DX-002

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameDX-002
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP2 receptor antagonistsProstanoid EP4 receptor antagonists
TargetsProstanoid EP2 receptorProstanoid EP4 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangDong NewOpp Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangDong NewOpp Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A